On March 10, 2020, Todd Brady notified the Board of Directors of Cocrystal Pharma, Inc. that he was resigning as a director, effective immediately. Mr. Brady was a member of the Audit Committee of the Board. He had been designated for election by certain stockholders of the Company pursuant to that certain Stockholder Rights Agreement, dated November 25, 2014.